Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)

This study has been completed.

Study NCT00114959 Information provided by Teva Pharmaceutical Industries

First Received: June 20, 2005 Last Updated: May 16, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2009
Primary Completion Date:	June 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: May 3, 2012